Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HER-2 Positive Malignant Carcinoma of Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03094052
What this trial is testing

Incidence and Severity of Diarrhea in Patients With HER2 Positive Breast Cancer Treated With Trastuzumab and Neratinib

Who this might be right for
HER2-positive Breast CancerBreast AdenocarcinomaStage II Breast Cancer AJCC v6 and v7+6 more
University of California, San Francisco 11
Early research (Phase 1)Active Not RecruitingNCT05809752
What this trial is testing

A First in Human Dose Escalation of Dendritic Cell Vaccine (DCV)

Who this might be right for
Leptomeningeal DiseaseTriple Negative Breast CancerHER2-positive Breast Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Large-scale testing (Phase 3)Looking for participantsNCT04254263
What this trial is testing

Adjuvant Study of Pyrotinib in HER-2 Positive Breast Cancer

Who this might be right for
Locally Advanced Breast Cancer
RenJi Hospital 316
Not applicableStudy completedNCT02286843
What this trial is testing

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

Who this might be right for
Breast Cancer MetastasesHER2 Positive Breast
Memorial Sloan Kettering Cancer Center 49
Large-scale testing (Phase 3)Study completedNCT03556358
What this trial is testing

Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer

Who this might be right for
Breast CancerBreast NeoplasmsHER2-positive Breast Cancer+2 more
Tanvex BioPharma USA, Inc. 809
Testing effectiveness (Phase 2)Study completedNCT03691493
What this trial is testing

Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Estrogen Receptor PositiveHER2/Neu Negative+4 more
Emory University 36
Testing effectiveness (Phase 2)WithdrawnNCT04419181
What this trial is testing

Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
University of Rochester
Not applicableActive Not RecruitingNCT06782698
What this trial is testing

Home-Based Exercise Program During Neoadjuvant Treatment to Improve Fatigue and Quality of Life in Early HER2-Positive and Triple-Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer (TNBC)HER2-Positive Breast CancerEarly Breast Cancer+2 more
Centro Hospitalar Universitário de Santo António 50
Not applicableStudy completedNCT05599334
What this trial is testing

A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

Who this might be right for
Breast CancerAdjuvant TherapyHER2-positive Breast Cancer
Pierre Fabre Medicament 111
Large-scale testing (Phase 3)Looking for participantsNCT01785420
What this trial is testing

Pre Operative Trastuzumab in Operable Breast Cancer

Who this might be right for
Carcinoma Breast Stage IHER2 Positive Breast Cancer
Dr Rajendra A. Badwe 1,100
Testing effectiveness (Phase 2)Ended earlyNCT03501979
What this trial is testing

Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD

Who this might be right for
Metastatic Breast CancerLeptomeningeal Disease
University of Alabama at Birmingham 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05252988
What this trial is testing

Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib

Who this might be right for
Early-stage Breast CancerHER2 Positive Breast CancerHormone Receptor Positive
Spanish Breast Cancer Research Group 177
Testing effectiveness (Phase 2)Study completedNCT02657343
What this trial is testing

An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.

Who this might be right for
Breast Cancer
Dana-Farber Cancer Institute 25
Large-scale testing (Phase 3)UnknownNCT00712140
What this trial is testing

Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

Who this might be right for
Breast Cancer
Warwick Medical School 4,000
Early research (Phase 1)Study completedNCT03281824
What this trial is testing

Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients

Who this might be right for
HER2-positive Breast Cancer
Alteogen, Inc. 27
Very early researchUnknownNCT05622240
What this trial is testing

99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT06928818
What this trial is testing

Trastuzumab Emtansine(T-DM1) After Trastuzumab Deruxtecan(T-DXd) in HER2-Positive Breast Cancer in Korea

Who this might be right for
Cancer of BreastTrastuzumab EmtansineTrastuzumab Deruxtecan
Seoul National University Hospital 100
Not applicableLooking for participantsNCT06035679
What this trial is testing

Pyrotinib Combined With Trastuzumab and Chemotherapy Neoadjuvant Therapy for HER2-positive Breast Cancer

Who this might be right for
Breast Cancer Female
Youzhi Zhu 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698186
What this trial is testing

Thero2-01S22 in HER2-positive Breast Cancer

Who this might be right for
HER2-positive Breast Cancer
Institut de cancérologie Strasbourg Europe 320
Not applicableNot Yet RecruitingNCT07540520
What this trial is testing

A Real-World Study on the Impact of Different Adjuvant Treatment Regimens on Prognosis in Non-pCR Patients With HER2-Positive Breast Cancer After Neoadjuvant Therapy

Who this might be right for
Early Breast Cancer
Hebei Medical University Fourth Hospital 2,000
Next Page